Acquired Immunodeficiency Syndrome: all 3,037 studies

Page 9 of 31. Open to participants first (307), then studies with results posted, then the rest; newest registration first within each.

• Study to Compare the Safety and Anti-HIV Effect of GSK1265744 Versus Placebo in HIV-1 Infected Adults (ITZ112929)CompletedNCT00920426Phase 2Results posted
• A Safety Study to Evaluate the Antiviral Activity of Darunavir in Combination With Ritonavir in HIV 1 Infected ChildrenCompletedNCT00919854Phase 2Results posted
• Comparing Blood Vessel Endothelial Function in HIV-Infected People and Matched HIV-Uninfected PeopleCompletedNCT00919724Results posted
• New Era Study: Treatment With Multi Drug Class (MDC) HAART in HIV Infected PatientsCompletedNCT00908544Not applicableResults posted
• HIV and Kidney Function StudyCompletedNCT00905151Results posted
• A Clinical Trial Comparing the Tolerability of Etravirine to Efavirenz in Combination With 2 Nucleoside/Nucleotide Reverse Transcriptase Inhibitors in Treatment-naive HIV-1 Infected PatientsCompletedNCT00903682Phase 2Results posted
• TMC125-TiDP2-C238: An Exploratory Pharmacokinetics, Safety and Anti-HIV Activity Study of Etravirine (ETR) When Given With Boosted Atazanavir (ATV/Rtv) at Two Different Doses and 1 Nucleoside Reverse Transcriptase Inhibitor (NRTI) in Treatment Experienced HIV PatientsCompletedNCT00896051Phase 2Results posted
• Treatment Effects of Escitalopram (Lexapro®) on Generalized Anxiety Disorder in Patients With HIV and AIDSCompletedNCT00887679Phase 3Results posted
• Atazanavir and Lamivudine for Treatment SimplificationCompletedNCT00885482Phase 4Results posted
• A Single-arm, Open-label, Study to Assess the Pharmacokinetics of Darunavir and Ritonavir, Darunavir and Cobicistat, Etravirine, and Rilpivirine in HIV-1 Infected Pregnant WomenCompletedNCT00855335Phase 3Results posted
• Minocycline for HIV+ Cognitive Impairment in UgandaTerminatedNCT00855062Phase 1/2Results posted
• Study To Investigate The Hemodynamic Effects Of Single Dose Vardenafil In Subjects Receiving MaravirocCompletedNCT00853840Phase 4Results posted
• Treatment of Acute Hepatitis C Virus in HIV Co-InfectionCompletedNCT00845676Phase 4Results posted
• A Study to Determine the Antiviral Activity of TMC310911 When Administered With Ritonavir in Treatment-Naive Human Immunodeficiency Virus - Type 1 (HIV-1) Infected PatientsCompletedNCT00838162Phase 2Results posted
• Drug Interactions Between Voriconazole and Atazanavir Coadministered as Atazanavir/Ritonavir in Healthy ParticipantsCompletedNCT00833482Phase 1Results posted
• Primary and Booster Vaccination Study With a Pneumococcal Vaccine in HIV Infected, HIV Exposed Uninfected and HIV Uninfected Children 6 to 10 Weeks of Age.CompletedNCT00829010Phase 3Results posted
• Pilot Study of a Raltegravir Based NRTI Sparing RegimenCompletedNCT00814879Not applicableResults posted
• Lopinavir/Ritonavir (Kaletra) PK in ChildrenCompletedNCT00810108Phase 4Results posted
• A Study to Evaluate the Pharmacokinetics, Safety, Tolerability, and Antiviral Activity of Rilpivirine (TMC278) in Human Immunodeficiency Virus Infected Adolescents and Children Aged Greater Than or Equal to 6 YearsCompletedNCT00799864Phase 2Results posted
• A Phase I Study of Quadrivalent Human Papilloma Virus (HPV) (Types 6, 11, 16, 18) Recombinant Vaccine in HIV-Infected and HIV-Negative Pre-Adolescents, Adolescents, and Young AdultsTerminatedNCT00798265Phase 1Results posted
• An Open Label Pharmacokinetic, Safety And Efficacy Study Of Maraviroc In Combination With Background Therapy For The Treatment Of HIV-1 Infected, CCR5 -Tropic ChildrenStatus unknownNCT00791700Phase 2Results posted
• Deep Vein Thrombosis Treatment With the Oral Direct Factor Xa Inhibitor Rivaroxaban in Patients Using a Strong CYP 3A4 InducerCompletedNCT00786422Phase 2Results posted
• Immune Reconstitution of Lopinavir/Ritonavir-Based vs Efavirenz-based HAART in Advanced HIV DiseaseTerminatedNCT00775606Phase 4Results posted
• A Study of Raltegravir in a Diverse Cohort of HIV-Infected Patients (0518-055)CompletedNCT00764946Phase 3Results posted
• Raltegravir vs. Atazanavir in Combination With Truvada® for the Treatment of Antiretroviral naïve HIV Infected PatientsCompletedNCT00762892Phase 4Results posted
• Changes in Triglyceride and Other Lipids (Levels of Fats Found in Blood) When Taking Darunavir Compared to Atazanavir in HIV-infected Patients That Have Never Received TreatmentCompletedNCT00757783Phase 4Results posted
• Lopinavir/r or Fosamprenavir/r Switch to Atazanavir/r or Darunavir/rCompletedNCT00756730Phase 4Results posted
• BRAVO: Background Regimen of Raltegravir on Virologic OutcomeCompletedNCT00751530Results posted
• Effectiveness of Armodafinil for Treating Fatigue in Adults With HIV/AIDSCompletedNCT00737204Phase 4Results posted
• Genetic Predictors of Raltegravir Penetration Into Cerebrospinal FluidCompletedNCT00729924Phase 2/3Results posted
• Pharmacokinetics, Safety And Toleration Of Maraviroc Administered To Subjects With Various Degrees Of Renal Impaired And Normal Renal FunctionCompletedNCT00717067Phase 4Results posted
• Study Comparing Lopinavir/Ritonavir (LPV/r) + Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) With a Nucleoside Sparing Regimen Consisting of Lopinavir/Ritonavir + Raltegravir (RAL)CompletedNCT00711009Phase 3Results posted
• Phase IIa Dose-ranging Study of GSK1349572 in HIV-1 Infected AdultsCompletedNCT00708110Phase 2Results posted
• Kaletra and Viread in Antiretroviral Naïve PatientsTerminatedNCT00679926Phase 4Results posted
• Eltrombopag To Reduce The Need For Platelet Transfusion In Subjects With Chronic Liver Disease And Thrombocytopenia Undergoing Elective Invasive ProceduresTerminatedNCT00678587Phase 3Results posted
• Raltegravir Augmentation on Persistent Central Nervous System (CNS) Immunoactivation in Treated HIV-1 PatientsCompletedNCT00672932Not applicableResults posted
• Prospective Observational Epidemiologic Study of Maraviroc's SafetyCompletedNCT00665561Results posted
• Pilot Project of Virologic and Immunologic Correlates of GALT Immune Reconstitution Following Raltegravir TherapyCompletedNCT00661960Not applicableResults posted
• Myocardial Function & FFA Metabolism in HIV Metabolic SyndromeCompletedNCT00656851Not applicableResults posted
• Raltegravir + Lopinavir/Ritonavir or Emtricitabine/Tenofovir for HIV Treatment Naive SubjectsCompletedNCT00654147Phase 2Results posted
• Exercise and Pioglitazone for HIV-Metabolic SyndromesCompletedNCT00639457Not applicableResults posted
• Pilot Study of Adding Raltegravir (MK-0518) to Antiretroviral Therapy in Patients With Low Level ViremiaCompletedNCT00618371Not applicableResults posted
• Safety and Immunogenicity of GlaxoSmithKline Biologicals' HPV Vaccine 580299 (Cervarix) in HIV Infected FemalesCompletedNCT00586339Phase 2Results posted
• Safety and Effectiveness of 3 Doses of Crofelemer Compared to Placebo in the Treatment of HIV Associated DiarrheaCompletedNCT00547898Phase 3Results posted
• Acupuncture and Relaxation Response for GI Symptoms and HIV Medication AdherenceCompletedNCT00545623Phase 2Results posted
• TMC278-TiDP6-C215: A Clinical Trial in Treatment Naive HIV-subjects Patients Comparing TMC278 to Efavirenz in Combination With 2 Nucleoside/Nucleotide Reverse Transcriptase InhibitorsCompletedNCT00543725Phase 3Results posted
• Efficacy Study of Substitution of Darunavir/Ritonavir (DRV/r) for Dual-boosted Protease InhibitorsCompletedNCT00543101Phase 4Results posted
• TMC278-TiDP6-C209: A Clinical Trial in Treatment Naive HIV-1 Patients Comparing TMC278 to Efavirenz in Combination With Tenofovir + Emtricitabine.CompletedNCT00540449Phase 3Results posted
• A Study to Evaluate the Pharmacokinetic Profile (How the Body Absorbs, Distributes, Metabolizes and Eliminates a Drug) of TMC125 Plus Tenofovir/Emtricitabine Once Daily With or Without Darunavir/r Once Daily in Antiretroviral (ARV) Naive HIV-1 Patients (Patients Have Never Received ARV Treatment).CompletedNCT00534352Phase 2Results posted
• Trial to Study the Effect of Dose of Herpes Simplex Virus-2 (HSV-2) Suppressive Therapy on HSV and HIVCompletedNCT00527618Phase 4Results posted
• A Study to Compare Effectiveness and Safety of Darunavir/Ritonavir (DRV/Rtv) 800mg/100mg Once Daily Versus DRV/Rtv 600mg/100mg Twice Daily in Early Treatment-Experienced HIV-1 Infected Patients (ODIN)CompletedNCT00524368Phase 3Results posted
• Pilot Study of Pyridostigmine Upon Immune Activation in HIV-1 Patients Who Have an Inadequate Immune ResponseCompletedNCT00518154Phase 2Results posted
• Multicenter, Safety Study Of MaravirocCompletedNCT00478231Phase 3Results posted
• Enfuvirtide/Current Protease Inhibitor Switch to PREZISTA (Darunavir)/Ritonavir + TMC125 in HIV Patients With Enfuvirtide Side Effects.CompletedNCT00460746Phase 3Results posted
• Treatment Simplification by Darunavir/Ritonavir 800/100 mg Once a Day Versus a Triple Combination Therapy With Darunavir/RitonavirCompletedNCT00458302Phase 3Results posted
• Treatment of Oral Warts in HIV+ PatientsCompletedNCT00454181Phase 2Results posted
• HIV-1 Infection Study of Once a Day Versus Twice a Day Protease Inhibitor in Antiretroviral Treatment Naive AdultsCompletedNCT00450580Phase 3Results posted
• Safety of EVG+RTV Administered With Other Antiretroviral Agents for the Treatment of HIV-1 InfectionCompletedNCT00445146Phase 2Results posted
• Dose-ranging Study to Evaluate the Safety & Immunogenicity of a HIV Vaccine 732461 in Healthy HIV Seronegative VolunteersCompletedNCT00434512Phase 2Results posted
• FOTO: Five Consecutive Days on Treatment With Efavirenz, Tenofovir, and Emtricitabine Followed by Two Days Off Treatment Versus Continuous TreatmentCompletedNCT00414635Phase 4Results posted
• Acyclovir to Treat Patients Co-infected With HIV and Herpes Viruses in UgandaCompletedNCT00405821Phase 2Results posted
• GRACE: A Study to Compare the Effectiveness, Safety and Tolerability of PREZISTA (Darunavir)/Ritonavir by Gender and Race When Administered With Other Antiretroviral Medications in Human Immunodeficiency Virus (HIV) Positive Women and Men.CompletedNCT00381303Phase 3Results posted
• A Study of an Investigational Regimen Combining FDA Approved HIV Drugs in HIV-Infected SubjectsCompletedNCT00363142Phase 3Results posted
• Safety and Efficacy of Tenofovir DF in HIV-1 Infected Adolescents Failing Their Current Antiretroviral TherapyCompletedNCT00352053Phase 3Results posted
• Investigation of V520 in a HIV Vaccine Dose Refinement Study (V520-027)(TERMINATED)TerminatedNCT00350623Phase 2Results posted
• Omega-3 Fatty Acids for High Triglycerides in HIV-infected PatientsCompletedNCT00346697Phase 4Results posted
• Antiretroviral Therapy for Advanced HIV Disease in South AfricaCompletedNCT00342355Phase 4Results posted
• Phase IIIb Study to Evaluate the Effectiveness and Safety of Atazanavir/Ritonavir as Single Enhanced Protease Inhibitor Therapy in Human Immunodeficiency Virus (HIV)-Infected Subjects Evidencing Virologic SuppressionCompletedNCT00337467Phase 3Results posted
• ALTAIR - Alternative Antiretroviral Strategies : a Comparison of Three Initial RegimensCompletedNCT00335322Phase 4Results posted
• A Study To Assess GW433908 (Fosamprenavir) Containing Regimens In HIV-1 Infected SubjectsCompletedNCT00296504Phase 3Results posted
• Chemotherapy and HAART to Treat AIDS-related Primary Brain LymphomaCompletedNCT00267865Phase 2Results posted
• Improving Treatment Adherence in HIV-Infected IndividualsCompletedNCT00247611Phase 2Results posted
• Study of Limited Versus Continuous Isoniazid Tuberculosis Preventive Therapy in HIV-infected Persons in BotswanaCompletedNCT00164281Phase 4Results posted
• Kaletra Sex/Gender Pharmacokinetics (PK) StudyCompletedNCT00148759Phase 4Results posted
• A Study With TMC125 in Human Immunodeficiency Virus (HIV) Type 1 Infected Patients, Who Were Treated With TMC125 Arm in a Sponsor-Selected TMC125 StudyCompletedNCT00128830Phase 2Results posted
• Effectiveness of Modafinil for Treating Fatigue in Adults With HIV/AIDSCompletedNCT00118378Phase 4Results posted
• Tenofovir Disoproxil Fumarate/Emtricitabine/Efavirenz Versus Combivir/Efavirenz in Antiretroviral-Naive HIV-1 Infected SubjectsCompletedNCT00112047Phase 3Results posted
• A Study of TMC278 in Human Immunodeficiency Virus Type 1 Infected Patients, Who Are Not Treated With Antiretroviral MedicinesCompletedNCT00110305Phase 2Results posted
• Safety and Efficacy of an Investigational Drug in Human Immunodeficiency Virus (HIV)-Infected Patients Failing Current Antiretroviral Therapies (0518-005)(COMPLETED)CompletedNCT00105157Phase 2Results posted
• Physiologic Growth Hormone Effects in HIV LipodystrophyCompletedNCT00100698Not applicableResults posted
• A Study to Evaluate the Safety and Efficacy of an Investigational Drug in HIV Infected Patients (0518-004)(COMPLETED)CompletedNCT00100048Phase 2Results posted
• Trial of Maraviroc (UK-427,857) in Combination With Zidovudine/Lamivudine Versus Efavirenz in Combination With Zidovudine/LamivudineCompletedNCT00098293Phase 3Results posted
• Investigation of V520 in an HIV Vaccine Proof-of-Concept Study (V520-023)TerminatedNCT00095576Phase 2Results posted
• Study Of An Investigational Regimen Including FDA Approved HIV Drugs In HIV-Infected Pediatric SubjectsCompletedNCT00071760Phase 2Results posted
• CSP #512 - Options in Management With Anti-RetroviralsCompletedNCT00050089Not applicableResults posted
• EPOCH and Rituximab to Treat Non-Hodgkin's Lymphoma in Patients With HIV InfectionCompletedNCT00006436Phase 2Results posted
• Phase II Study of the Efficacy of Peptide T in HIV-Positive Individuals With Cognitive Impairment.CompletedNCT00000392Phase 2Results posted
• Studies of the Ocular Complications of AIDS (SOCA)--Cytomegalovirus Retinitis Retreatment Trial (CRRT)CompletedNCT00000134Phase 3Results posted
• Prevalence and Genotype Distribution of HPV Infection Among People Living With HIV in ColombiaCompletedNCT07934992
• CD4 Cell Count at Antiretroviral Therapy Initiation or Re- InitiationSuspendedNCT07760324
• Bioequivalence Study of ADC118 Tablets in Healthy Chinese Volunteers Under Fasting ConditionsCompletedNCT07753902Phase 1
• Implementation and Assessment of a Medication Therapy Management Program in HIV Patients at High Risk of Adverse Drug Events at Khartoum, SudanCompletedNCT07750834Not applicable
• Improving Management of Recipients of Care With HIV Viremia to Optimize Viral Suppression in Zambia: A Process and Outcome EvaluationCompletedNCT07747987Not applicable
• Efficacy and Safety of the ACC017-Based Antiretroviral Regimen in Treatment-Experienced Adults With HIV-1 Harboring Non-Nucleoside Reverse Transcriptase Inhibitor Resistance MutationsActive, not recruitingNCT07711210Phase 1/2
• Long-Term Real-World Evidence Study to Evaluate Effectiveness, Persistence, Adherence, Safety and Tolerability of Long-acting Cabotegravir Plus Rilpivirine.Active, not recruitingNCT07703748
• Comparison of Acceptance and Commitment Therapy and Cognitive Behavior Therapy: Managing Psychological Distress and Its Multifaceted Impact on Stigmatization, Psychological Wellbeing, Social Support and Treatment Adherence in HIV/AIDS PatientsActive, not recruitingNCT07652918Not applicable
• Income Generation, Food and Nutrient Security for Improved Livelihoods and Health Outcomes Among HIV-Positive, KenyaCompletedNCT07620197Not applicable
• ComBaCaL HIV Prevention TwiCsWithdrawnNCT07581600Not applicable
• Southern Sichuan HIV Cohort Study ProtocolActive, not recruitingNCT07519538
• Evaluation of the Effectiveness of the HPV Education Program Applied to WomenCompletedNCT07468487Not applicable

← Acquired Immunodeficiency Syndrome overview